Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2OSL

Crystal structure of Rituximab Fab in complex with an epitope peptide

2OSL の概要
エントリーDOI10.2210/pdb2osl/pdb
分子名称light chain of the Rituximab Fab fragment,light chain of the Rituximab Fab fragment, heavy chain of the Rituximab Fab fragment,heavy chain of the Rituximab Fab fragment, B-lymphocyte antigen CD20, ... (4 entities in total)
機能のキーワードfab-peptide complex, rituximab, chimeric antibody, immune system
由来する生物種Mus musculus (house mouse)
詳細
タンパク質・核酸の鎖数6
化学式量合計99328.43
構造登録者
Du, J.,Zhong, C.,Ding, J. (登録日: 2007-02-06, 公開日: 2007-04-10, 最終更新日: 2024-10-16)
主引用文献Du, J.,Wang, H.,Zhong, C.,Peng, B.,Zhang, M.,Li, B.,Huo, S.,Guo, Y.,Ding, J.
Structural basis for recognition of CD20 by therapeutic antibody Rituximab
J.Biol.Chem., 282:15073-15080, 2007
Cited by
PubMed Abstract: Rituximab is a widely used monoclonal antibody drug for treating certain lymphomas and autoimmune diseases. To understand the molecular mechanism of recognition of human CD20 by Rituximab, we determined the crystal structure of the Rituximab Fab in complex with a synthesized peptide comprising the CD20 epitope (residues 163-187) at 2.6-A resolution. The combining site of the Fab consists of four complementarity determining regions that form a large, deep pocket to accommodate the epitope peptide. The bound peptide assumes a unique cyclic conformation that is constrained by a disulfide bond and a rigid proline residue (Pro(172)). The (170)ANPS(173) motif of CD20 is deeply embedded into the pocket on the antibody surface and plays an essential role in the recognition and binding of Rituximab. The antigen-antibody interactions involve both hydrogen bonds and van der Waals contacts and display a high degree of structural and chemical complementarity. These results provide a molecular basis for the specific recognition of CD20 by Rituximab as well as valuable information for development of improved antibody drugs with better specificity and higher affinity.
PubMed: 17395584
DOI: 10.1074/jbc.M701654200
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.6 Å)
構造検証レポート
Validation report summary of 2osl
検証レポート(詳細版)ダウンロードをダウンロード

251801

件を2026-04-08に公開中

PDB statisticsPDBj update infoContact PDBjnumon